Skip to main content

Calcitonin

  • Living reference work entry
  • First Online:
Encyclopedia of Cancer
  • 43 Accesses

Definition

Calcitonin (CT) is a 32-amino acid peptide synthesized in mammals by the C cells of the thyroid gland. Several extrathyroidal sites including the prostate gland, gastrointestinal tract, thymus, bladder, lung, pituitary gland, and central nervous system (CNS) also produce this peptide molecule (Ball 2007).

Characteristics

Almost all cells of human body synthesize and secrete procalcitonin (proCT), a precursor of the CT peptide, in response to infection/inflammation. Only cells of the thyroid and neuroendocrine organs can process proCT to produce mature CT molecule (Davies 2015). CT sequence among various species shows remarkable divergence (Steinwald et al. 1999). However, all sequences contain 32 amino acids, a carboxy-terminal proline amide, and a disulfide bridge between cysteine residues at positions 1 and 7. In addition to CT, other biologically and chemically diverse molecules such as CT gene-related peptide (CGRP), adrenomedullin(AFP-modern), and amylin (AMY) are...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Ball DW (2007) Medullary thyroid cancer: therapeutic targets and molecular markers. Curr Opin Oncol 19(1):18–23

    Article  CAS  PubMed  Google Scholar 

  • Barwell J, Gingell JJ, Watkins HA, Archbold JK, Poyner DR, Hay DL (2012) Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs? Brit J Pharmacol 166(1):51-65. doi:10.1111/j.1476-5381.2011.01525.x.

    Article  CAS  Google Scholar 

  • Davies J (2015) Procalcitonin. J Clin Pathol 68: 675–79

    Article  CAS  PubMed  Google Scholar 

  • Findlay DM, Saxton PM (2003) Calcitonin. In: Henry HL, Normon AW (eds) Encyclopedia of hormones and related cell regulators. Academic, New York, pp 220–230

    Chapter  Google Scholar 

  • Han B, Nakamura M, Zhou G et al (2006) Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen actor and uPA receptor. Int J Oncol 28(4):807–814

    CAS  PubMed  Google Scholar 

  • ondel M (2000) Calcitonin and calcitonin receptors: bone and beyond. Int J Exp Pathol 81(6):405–422

    Google Scholar 

  • Seck T, Pellegrini M, Florea AM et al (2005) The delta e13 isoform of the calcitonin receptor forms six transmembrane domain receptor with dominant negative effects on receptor surface expression and signaling. Mol Endocrinol 19(8):2132–2133

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Steinwald PM, Whang KT, Becker KL, Snider RH, Nylen ES, White JC (1999) Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis. Critical Care 3(1):11–16

    Google Scholar 

  • Thomas S, Chigurupati S, Anbalagan M, Shah G (2006) Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor. Mol Endocrinol 20(8):1894–1911

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Girish V. Shah .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Shah, G.V. (2015). Calcitonin. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_776-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27841-9_776-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27841-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics